1.
Silverberg J, Barbarot S, Gooderham M, Simon J, Simpson E, Kurbasic A, Olsen C, Cork M. Specifically Targeting Interleukin-13 with Tralokinumab Improved Sleep in Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials in Patients with Atopic Dermatitis. J of Skin [Internet]. 2021Jan.1 [cited 2022Aug.13];5(1):s9. Available from: https://jofskin.org/index.php/skin/article/view/1162